Michael R. Olin

2.4k total citations · 1 hit paper
46 papers, 1.6k citations indexed

About

Michael R. Olin is a scholar working on Immunology, Oncology and Neurology. According to data from OpenAlex, Michael R. Olin has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 16 papers in Oncology and 11 papers in Neurology. Recurrent topics in Michael R. Olin's work include Immunotherapy and Immune Responses (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Immune cells in cancer (11 papers). Michael R. Olin is often cited by papers focused on Immunotherapy and Immune Responses (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (11 papers) and Immune cells in cancer (11 papers). Michael R. Olin collaborates with scholars based in United States, China and Canada. Michael R. Olin's co-authors include Thomas W. Molitor, Phillip K. Peterson, R. Bryan Rock, Cristina Baker, John R. Ohlfest, Christopher A. Pennell, Michael W. Graner, G. Elizabeth Pluhar, Zhengming Xiong and Christopher L. Moertel and has published in prestigious journals such as Nature Communications, The Journal of Immunology and Cancer Research.

In The Last Decade

Michael R. Olin

44 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Central Nervous System Tuberculosis: Pathogenesis and Clinical Aspects

2008 481 citations Michael R. Olin, Thomas W. Molitor et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael R. Olin United States	25	519	442	392	313	294	46	1.6k
Nieves Doménech Spain	23	781 1.5×	396 0.9×	236 0.6×	770 2.5×	263 0.9×	71	2.1k
Peter R. A. Johnson Australia	23	530 1.0×	239 0.5×	246 0.6×	604 1.9×	186 0.6×	36	2.6k
Kristi L. Peters United States	15	951 1.8×	115 0.3×	172 0.4×	486 1.6×	275 0.9×	28	1.6k
Takao Kotani Japan	20	172 0.3×	160 0.4×	162 0.4×	393 1.3×	113 0.4×	106	1.4k
Henry B. Warren United States	16	714 1.4×	114 0.3×	196 0.5×	813 2.6×	265 0.9×	19	2.2k
Ben Roediger Australia	28	2.0k 3.8×	452 1.0×	194 0.5×	538 1.7×	264 0.9×	58	3.2k
Egbert Flory Germany	27	1.0k 2.0×	196 0.4×	436 1.1×	1.2k 4.0×	336 1.1×	59	3.0k
Patricia Menten Belgium	19	1.0k 2.0×	91 0.2×	154 0.4×	478 1.5×	993 3.4×	24	2.1k
Robert Kammerer Germany	26	764 1.5×	130 0.3×	84 0.2×	596 1.9×	682 2.3×	62	2.0k
Sandra Zurawski United States	24	2.2k 4.1×	232 0.5×	194 0.5×	702 2.2×	415 1.4×	40	3.2k

Countries citing papers authored by Michael R. Olin

Since Specialization

Citations

This map shows the geographic impact of Michael R. Olin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael R. Olin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael R. Olin more than expected).

Fields of papers citing papers by Michael R. Olin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael R. Olin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael R. Olin. The network helps show where Michael R. Olin may publish in the future.

Co-authorship network of co-authors of Michael R. Olin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael R. Olin. A scholar is included among the top collaborators of Michael R. Olin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael R. Olin. Michael R. Olin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Raphael, Itay, et al.. (2024). Glioblastoma vaccines: past, present, and opportunities. EBioMedicine. 100. 104963–104963. 45 indexed citations

Webb, Mason, Jacob P. van Vloten, Laura Evgin, et al.. (2024). Expression of tumor antigens within an oncolytic virus enhances the anti-tumor T cell response. Nature Communications. 15(1). 5442–5442. 37 indexed citations

Shanley, Ryan, Jessica Lawrence, Michael R. Olin, et al.. (2023). Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma. Frontiers in Immunology. 14. 1284118–1284118.

Schrock, Morgan S., Anna Bratasz, Margaret A. Miller, et al.. (2023). Establishment and characterization of two novel patient‐derived lines from canine high‐grade glioma. Veterinary and Comparative Oncology. 21(3). 492–502. 1 indexed citations

Moertel, Christopher L., G. Elizabeth Pluhar, & Michael R. Olin. (2023). TRLS-09. USE OF A PAN-PEPTIDE CHECKPOINT INHIBITOR IN THE TREATMENT OF CENTRAL NERVOUS SYSTEM TUMORS. Neuro-Oncology. 25(Supplement_1). i81–i81. 1 indexed citations

Alghamri, Mahmoud S., Brandon L. McClellan, Santiago Haase, et al.. (2021). Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments. Frontiers in Pharmacology. 12. 680021–680021. 53 indexed citations

Sham, Yuk Y., Ayman Taher, María G. Castro, et al.. (2021). CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway. Neurotherapeutics. 18(3). 1980–1994. 8 indexed citations

Xiong, Zhengming, G. Elizabeth Pluhar, Susan K. Rathe, et al.. (2019). CD200 Checkpoint Reversal: A Novel Approach to Immunotherapy. Clinical Cancer Research. 26(1). 232–241. 25 indexed citations

Olin, Michael R., Christopher A. Pennell, Aaron L. Sarver, et al.. (2019). Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma. Cancers. 11(2). 137–137. 31 indexed citations

10.

Graner, Michael W., et al.. (2018). Tumor-derived exosomes, microRNAs, and cancer immune suppression. Seminars in Immunopathology. 40(5). 505–515. 71 indexed citations

11.

Andersen, Brian M., Alan L. Epstein, John R. Ohlfest, et al.. (2016). Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant. Journal for ImmunoTherapy of Cancer. 4(1). 11–11. 25 indexed citations

12.

Olin, Michael R., Walter C. Low, David H. McKenna, et al.. (2014). Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4+IL17+ response. Journal for ImmunoTherapy of Cancer. 2(1). 4–4. 36 indexed citations

13.

Pluhar, G. Elizabeth, Charles E. Seiler, Michelle R. Goulart, et al.. (2013). Vaccination for Invasive Canine Meningioma Induces In Situ Production of Antibodies Capable of Antibody-Dependent Cell-Mediated Cytotoxicity. Cancer Research. 73(10). 2987–2997. 37 indexed citations

14.

Murphy, Katherine A., Melissa G. Lechner, Flavia E. Popescu, et al.. (2012). An In Vivo Immunotherapy Screen of Costimulatory Molecules Identifies Fc-OX40L as a Potent Reagent for the Treatment of Established Murine Gliomas. Clinical Cancer Research. 18(17). 4657–4668. 29 indexed citations

15.

Olin, Michael R., Brian M. Andersen, Adam J. Litterman, et al.. (2011). Oxygen Is a Master Regulator of the Immunogenicity of Primary Human Glioma Cells. Cancer Research. 71(21). 6583–6589. 17 indexed citations

16.

Olin, Michael R., Sabita Roy, & Thomas W. Molitor. (2010). In Vivo Morphine Treatment Synergistically Increases LPS-Induced Caspase Activity in Immune Organs. Journal of Neuroimmune Pharmacology. 5(4). 546–552. 5 indexed citations

17.

Lee, Brian W., Michael R. Olin, Gary L. Johnson, & Robert J. Griffin. (2008). In Vitro and In Vivo Apoptosis Detection Using Membrane Permeant Fluorescent-Labeled Inhibitors of Caspases. Humana Press eBooks. 414. 109–135. 25 indexed citations

18.

Olin, Michael R., et al.. (2006). Morphine modulates γδ lymphocytes cytolytic activity following BCG vaccination. Brain Behavior and Immunity. 21(2). 195–201. 9 indexed citations

19.

Olin, Michael R., Laura Batista, Zhengguo Xiao, et al.. (2005). γδ Lymphocyte Response to Porcine Reproductive and Respiratory Syndrome Virus. Viral Immunology. 18(3). 490–499. 41 indexed citations

20.

Olin, Michael R., et al.. (2004). γδ T-lymphocyte cytotoxic activity against Mycobacterium bovis analyzed by flow cytometry. Journal of Immunological Methods. 297(1-2). 1–11. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact